Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLGN CollPlant Biotechnologies	$1.86 -3.6%	$2.63	$1.86 ▼ $6.75	$21.31M	1.24	11,301 shs	6,259 shs
MHUA Meihua International Medical Technologies	$0.29 +2.6%	$0.31	$0.25 ▼ $1.47	$7.23M	0.48	661,349 shs	49,352 shs
NXL Nexalin Technology	$1.25 -0.8%	$1.93	$0.53 ▼ $4.49	$16.66M	4.67	1.24 million shs	193,624 shs
PTHL Pheton Holdings Ltd Class A Ordinary Shares	$4.44 +8.3%	$3.34	$1.32 ▼ $6.45	$29.22M	N/A	135,650 shs	687,493 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLGN CollPlant Biotechnologies	-7.62%	-15.28%	-19.00%	-48.27%	-67.01%
MHUA Meihua International Medical Technologies	+3.65%	-2.06%	-9.42%	-13.87%	-58.71%
NXL Nexalin Technology	-5.26%	-30.77%	-25.44%	-64.80%	-8.70%
PTHL Pheton Holdings Ltd Class A Ordinary Shares	+9.04%	+31.41%	+22.02%	+37.58%	+409,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLGN CollPlant Biotechnologies	1.9848 of 5 stars	3.7	3.0	0.0	0.0	0.6	0.0	1.3
MHUA Meihua International Medical Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	2.6736 of 5 stars	3.5	3.0	0.0	0.0	2.7	3.3	0.0
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLGN CollPlant Biotechnologies	3.33	Buy	$12.50	572.04% Upside
MHUA Meihua International Medical Technologies	0.00	N/A	N/A	N/A
NXL Nexalin Technology	3.00	Buy	$5.00	300.00% Upside
PTHL Pheton Holdings Ltd Class A Ordinary Shares	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest MHUA, PTHL, CLGN, and NXL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/27/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00
3/24/2025	NXL Nexalin Technology	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$5.00
2/12/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00

(Data available from 5/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLGN CollPlant Biotechnologies	$515K	41.37	N/A	N/A	$2.47 per share	0.75
MHUA Meihua International Medical Technologies	$96.91M	0.07	$0.42 per share	0.69	$6.13 per share	0.05
NXL Nexalin Technology	$168.72K	98.74	N/A	N/A	$0.43 per share	2.91
PTHL Pheton Holdings Ltd Class A Ordinary Shares	$448.20K	65.20	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLGN CollPlant Biotechnologies	-$7.02M	-$1.46	N/A	N/A	N/A	-2,680.00%	-77.05%	-61.43%	5/27/2025 (Estimated)
MHUA Meihua International Medical Technologies	$11.62M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	-$4.65M	-$0.82	N/A	∞	N/A	-3,407.98%	-187.59%	-167.21%	5/9/2025 (Estimated)
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest MHUA, PTHL, CLGN, and NXL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
6/4/2025	Q1 2025	CLGN CollPlant Biotechnologies	-$0.37	N/A	N/A	N/A	N/A	N/A
3/26/2025	Q4 2024	CLGN CollPlant Biotechnologies	-$0.42	-$0.34	+$0.08	-$0.34	$0.36 million	$0.17 million
3/14/2025	Q4 2024	NXL Nexalin Technology	N/A	-$0.28	N/A	-$0.28	N/A	$0.03 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLGN CollPlant Biotechnologies	N/A	N/A	N/A	N/A	N/A
MHUA Meihua International Medical Technologies	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	N/A	N/A	N/A	N/A	N/A
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLGN CollPlant Biotechnologies	N/A	5.38	5.23
MHUA Meihua International Medical Technologies	N/A	4.78	4.74
NXL Nexalin Technology	N/A	16.42	15.89
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLGN CollPlant Biotechnologies	21.69%
MHUA Meihua International Medical Technologies	1.17%
NXL Nexalin Technology	0.65%
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A

Insider Ownership

Company	Insider Ownership
CLGN CollPlant Biotechnologies	9.60%
MHUA Meihua International Medical Technologies	66.56%
NXL Nexalin Technology	24.00%
PTHL Pheton Holdings Ltd Class A Ordinary Shares	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLGN CollPlant Biotechnologies	70	11.46 million	10.36 million	Optionable
MHUA Meihua International Medical Technologies	620	25.08 million	8.39 million	Not Optionable
NXL Nexalin Technology	3	13.33 million	10.11 million	Not Optionable
PTHL Pheton Holdings Ltd Class A Ordinary Shares	11	6.58 million	N/A	N/A

MHUA, PTHL, CLGN, and NXL Headlines

Recent News About These Companies

Pheton Holdings Ltd Announces Closing of Initial Public Offering

September 6, 2024 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MHUA, PTHL, CLGN, and NXL Company Descriptions

CollPlant Biotechnologies NASDAQ:CLGN

$1.88 -0.05 (-2.59%)

As of 04:00 PM Eastern

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

Meihua International Medical Technologies NASDAQ:MHUA

$0.29 +0.01 (+2.64%)

Closing price 03:56 PM Eastern

Extended Trading

$0.29 0.00 (-0.76%)

As of 07:18 PM Eastern

Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Nexalin Technology NASDAQ:NXL

$1.25 -0.01 (-0.79%)

Closing price 03:58 PM Eastern

Extended Trading

$1.18 -0.07 (-5.60%)

As of 05:49 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Pheton Holdings Ltd Class A Ordinary Shares NASDAQ:PTHL

$4.44 +0.34 (+8.29%)

Closing price 03:59 PM Eastern

Extended Trading

$4.25 -0.19 (-4.37%)

As of 04:49 PM Eastern

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time